Safety and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): Analysis of MO19391 according to CT Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pierga, J
  • Pritchard, Kathleen
  • Thomssen, C
  • Cortes-Funes, H
  • Biganzoli, L
  • Padrik, P
  • Zvirbule, Z
  • Smith, I

publication date

  • May 20, 2009